Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors.
Angiotensin-I converting enzyme (ACE) is a two-domain dipeptidylcarboxypeptidase involved in regulating blood pressure via the kallikrein-kininand renin-angiotensin-aldosterone complex. Therefore, ACE is a key drug target for the treatment of cardiovascular system diseases. At present many works are...
Main Authors: | Li Fang, Mingxian Geng, Chunlei Liu, Ji Wang, Weihong Min, Jingsheng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0215609 |
Similar Items
-
Angiotensin-converting enzyme inhibitors
by: David García Barreto, et al.
Published: (2014-03-01) -
A molecular basis for the C-domain selectivity of angiotensin-converting enzyme
by: Kröger, Wendy Lee
Published: (2014) -
A Molecular Basis for the C-Domain Selectivity of Angiotensin-Converting Enzyme
by: Kroger, W
Published: (2014) -
Studies on the inhibitors of angiotensin converting enzyme
by: Hodsman, G. P.
Published: (1983) -
Angiotensin Converting Enzyme Inhibitor/Angiotensin II Receptor Blockers and Pneumonia risk
by: Chia-Lin Liu, et al.
Published: (2010)